Novel oncoprotein EPS8: a new target for anticancer therapy

Yu-Hua Li1, Tong-Yuan Xue, Ying-Zhi He

  • 1Department of Hematology, Zhujiang Hospital, Southern Medical University, 510282 Guangzhou, China.

Insights

The EPS8 protein is overexpressed in many cancers and drives tumor growth and spread. Targeting EPS8 may offer a new therapeutic strategy for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Epidermal growth factor receptor (EGFR) substrate 8 (EPS8) is a tyrosine kinase substrate involved in EGFR-mediated mitogenic signaling.
  • EPS8 is frequently overexpressed in various cancers, including breast, colon, and cervical cancers, as well as hematologic malignancies.
  • Its involvement in key cellular processes like tumorigenesis, proliferation, migration, and metastasis highlights its significance in cancer progression.

Purpose of the Study:

  • To provide a comprehensive overview of EPS8's role in cellular functions.
  • To elucidate the significance of EPS8 in tumorigenesis.
  • To explore the potential of EPS8 as a therapeutic target for cancer.

Main Methods:

  • Literature review of existing research on EPS8.
  • Analysis of signaling pathways involving EPS8.
  • Evaluation of EPS8's role in cancer progression and prognosis.

Main Results:

  • EPS8 overexpression is linked to poor prognosis in cancer patients.
  • EPS8 participates in multiple signaling pathways crucial for cancer development.
  • EPS8's functions extend to cell proliferation, migration, and metastasis.

Conclusions:

  • EPS8 plays a critical role in various cellular processes relevant to cancer.
  • The overexpression and functional significance of EPS8 position it as a potential therapeutic target.
  • Targeting EPS8 may represent a promising strategy for cancer therapy.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K